Literature DB >> 10637293

Ultraviolet light induces redox reaction-mediated dimerization and superactivation of oncogenic Ret tyrosine kinases.

M Kato1, T Iwashita, K Takeda, A A Akhand, W Liu, M Yoshihara, N Asai, H Suzuki, M Takahashi, I Nakashima.   

Abstract

The c-RET proto-oncogene encodes a receptor-type tyrosine kinase, and its mutations in the germ line are responsible for the inheritance of multiple endocrine neoplasia type 2A (MEN2A) and 2B (MEN2B). Ret kinases are constitutively activated as a result of MEN2A mutations (Ret-MEN2A) or MEN2B mutations (Ret-MEN2B). Here we demonstrate that UV light (UV) irradiation induces superactivation of the constitutively activated Ret-MEN2A and Ret-MEN2B as well as activation of c-Ret. Before UV irradiation, small percentages of c-Ret (3-4%) and Ret-MEN2B (1-2%) and large percentages of Ret-MEN2A (30-40%) were dimerized through disulfide bonds. These dimerized Ret proteins were preferentially autophosphorylated, suggesting a close relation between up-regulated kinase activity and disulfide bond-mediated dimerization of Ret proteins. We found that UV irradiation promotes the disulfide bond-mediated dimerization of the Ret proteins, in close association with activation and superactivation of Ret kinases. UV irradiation also induced dimerization and activation of the extracellular domain-deleted mutant Ret (Ret-PTC-1). Interestingly, the levels of basic kinase activity and dimerization of Ret-PTC-1-C376A, in which cysteine 376 in the tyrosine kinase domain of Ret-PTC-1 was replaced by alanine, were low and were not increased by UV irradiation. These results suggest that Ret-PTC-1 cysteine 376 is one of possibly multiple critical target amino acids of UV for Ret kinase activation. Overexpression of Cu/Zn superoxide dismutase in cells as a result of gene transfection prevented both the UV-mediated promotion of dimerization and the superactivation of Ret-MEN2A kinase. These results suggest that the UV-induced free radicals in cells attack intracellular domains of Ret to dimerize the kinase proteins for superactivation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10637293      PMCID: PMC14759          DOI: 10.1091/mbc.11.1.93

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  29 in total

1.  The kit ligand: a cell surface molecule altered in steel mutant fibroblasts.

Authors:  J G Flanagan; P Leder
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

2.  cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line.

Authors:  Y Ishizaka; T Ushijima; T Sugimura; M Nagao
Journal:  Biochem Biophys Res Commun       Date:  1990-04-30       Impact factor: 3.575

3.  Clustered cysteine residues in the kinase domain of v-Src: critical role for protein stability, cell transformation and sensitivity to herbimycin A.

Authors:  T Senga; K Miyazaki; K Machida; H Iwata; S Matsuda; I Nakashima; M Hamaguchi
Journal:  Oncogene       Date:  2000-01-13       Impact factor: 9.867

4.  PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

Authors:  M Grieco; M Santoro; M T Berlingieri; R M Melillo; R Donghi; I Bongarzone; M A Pierotti; G Della Porta; A Fusco; G Vecchio
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

Review 5.  The role of the ret proto-oncogene in human disease.

Authors:  M Takahashi
Journal:  Nagoya J Med Sci       Date:  1997-03       Impact factor: 1.131

6.  Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors.

Authors:  C Rosette; M Karin
Journal:  Science       Date:  1996-11-15       Impact factor: 47.728

7.  Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse lines.

Authors:  M Kato; W Liu; A A Akhand; Y Dai; M Ohbayashi; T Tuzuki; H Suzuki; K Isobe; M Takahashi; I Nakashima
Journal:  Oncogene       Date:  1999-01-21       Impact factor: 9.867

8.  Transgenic mouse model for skin malignant melanoma.

Authors:  M Kato; M Takahashi; A A Akhand; W Liu; Y Dai; S Shimizu; T Iwamoto; H Suzuki; I Nakashima
Journal:  Oncogene       Date:  1998-10-08       Impact factor: 9.867

9.  The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice.

Authors:  M Kato; W Liu; H Yi; N Asai; A Hayakawa; K Kozaki; M Takahashi; I Nakashima
Journal:  J Invest Dermatol       Date:  1998-10       Impact factor: 8.551

10.  Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene.

Authors:  T Iwamoto; M Takahashi; M Ito; K Hamatani; M Ohbayashi; W Wajjwalku; K Isobe; I Nakashima
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

View more
  19 in total

1.  Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth.

Authors:  Elisa Giannoni; Francesca Buricchi; Giovanni Raugei; Giampietro Ramponi; Paola Chiarugi
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

2.  Manganese-Mediated Decrease in Levels of c-RET and Tyrosine Hydroxylase Expression In Vitro.

Authors:  Mayuko Y Kumasaka; Ichiro Yajima; Nobutaka Ohgami; Hiromasa Ninomiya; Machiko Iida; Xiang Li; Reina Oshino; Hiroko Tanihata; Masafumi Yoshinaga; Masashi Kato
Journal:  Neurotox Res       Date:  2017-07-20       Impact factor: 3.911

3.  Differential contributions of rare and common, coding and noncoding Ret mutations to multifactorial Hirschsprung disease liability.

Authors:  Eileen Sproat Emison; Merce Garcia-Barcelo; Elizabeth A Grice; Francesca Lantieri; Jeanne Amiel; Grzegorz Burzynski; Raquel M Fernandez; Li Hao; Carl Kashuk; Kristen West; Xiaoping Miao; Paul K H Tam; Paola Griseri; Isabella Ceccherini; Anna Pelet; Anne-Sophie Jannot; Loic de Pontual; Alexandra Henrion-Caude; Stanislas Lyonnet; Joke B G M Verheij; Robert M W Hofstra; Guillermo Antiñolo; Salud Borrego; Andrew S McCallion; Aravinda Chakravarti
Journal:  Am J Hum Genet       Date:  2010-07-09       Impact factor: 11.025

Review 4.  c-Ret-mediated hearing losses.

Authors:  Nobutaka Ohgami; Haruka Tamura; Kyoko Ohgami; Machiko Iida; Ichiro Yajima; Mayuko Y Kumasaka; Yuji Goto; Michihiko Sone; Tsutomu Nakashima; Masashi Kato
Journal:  Int J Clin Exp Pathol       Date:  2012-01-01

Review 5.  A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.

Authors:  Cristina Romei; Raffaele Ciampi; Rossella Elisei
Journal:  Nat Rev Endocrinol       Date:  2016-02-12       Impact factor: 43.330

6.  Functional relevance of the disulfide-linked complex of the N-terminal PDZ domain of InaD with NorpA.

Authors:  M E Kimple; D P Siderovski; J Sondek
Journal:  EMBO J       Date:  2001-08-15       Impact factor: 11.598

7.  c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell lines.

Authors:  Yuichiro Ohshima; Ichiro Yajima; Kozue Takeda; Machiko Iida; Mayuko Kumasaka; Yoshinari Matsumoto; Masashi Kato
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

8.  Two conserved cysteine residues are critical for the enzymic function of the human platelet-derived growth factor receptor-beta: evidence for different roles of Cys-822 and Cys-940 in the kinase activity.

Authors:  Joon-Won Lee; Jee-Eun Kim; Eun-Jung Park; Jin-Hyun Kim; Chang-Hun Lee; Seung-Rock Lee; Jongbum Kwon
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

Review 9.  Biological chemistry and functionality of protein sulfenic acids and related thiol modifications.

Authors:  Nelmi O Devarie-Baez; Elsa I Silva Lopez; Cristina M Furdui
Journal:  Free Radic Res       Date:  2015-11-11

Review 10.  Downstream targets and intracellular compartmentalization in Nox signaling.

Authors:  Kai Chen; Siobhan E Craige; John F Keaney
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.